These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14129238)

  • 1. FIBRINOLYTIC BLEEDING AND ITS CONTROL.
    SHERRY S; FLETCHER AP; ALKJAERSIG NK
    Am Heart J; 1964 Mar; 67():425-7. PubMed ID: 14129238
    [No Abstract]   [Full Text] [Related]  

  • 2. [HEMORRHAGIC DIATHESIS CAUSED BY HIGH FIBRINOLYTIC ACTIVITY OF THE BLOOD].
    MAZURIN AV; PLAKHUTA TG
    Vopr Okhr Materin Det; 1965 Feb; 10():54-8. PubMed ID: 14259090
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fibrinolysis and the hemorrhagic fibrinolytic states].
    RUSSO G; MASTROMONACO A
    Ann Med Nav (Roma); 1960; 65():131-50. PubMed ID: 14440337
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fibrinolysis and fibrinolytic hemorrhagic diatheses].
    FAVRE-GILLY J; POTTON F
    J Med Lyon; 1952 Oct; 33(786):869-81. PubMed ID: 13023221
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products.
    FLETCHER AP; ALKJAERSIG N; SHERRY S
    J Clin Invest; 1962 Apr; 41(4):896-916. PubMed ID: 13893560
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization.
    ALKJAERSIG N; FLETCHER AP; SHERRY S
    J Clin Invest; 1962 Apr; 41(4):917-34. PubMed ID: 13860492
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. III. Demonstration of abnormal clot structure by electron microscopy.
    BANG NU; FLETCHER AP; ALKJAERSIG N; SHERRY S
    J Clin Invest; 1962 Apr; 41(4):935-48. PubMed ID: 13864646
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fibrinolysis in pregnancy interrupted by Rh sensitivity; considerations on fibrinolytic hemorrhagic diathesis].
    FAVRE-GILLY J
    Rev Hematol; 1952; 7(1):60-71. PubMed ID: 14949747
    [No Abstract]   [Full Text] [Related]  

  • 9. [HEMORRHAGIC DIATHESIS CAUSED BY HYPERFIBRINOLYSIS].
    PERLICK E
    Z Gesamte Inn Med; 1965 Mar; 20():SUPPL:292-6. PubMed ID: 14306478
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hemorrhagic diathesis due to coagulative and fibrinolytic abnormalities].
    Terao A
    Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):209-13. PubMed ID: 11031932
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blood coagulation studies to discover the pathologically increased fibrinolytic activity of the blood that causes hemorrhage].
    Enev N
    Vutr Boles; 1978; 17(3):41-5. PubMed ID: 150133
    [No Abstract]   [Full Text] [Related]  

  • 12. [Locoregional anesthesia in patients who have received fibrinolytic medication].
    Peramo Fernández F; Vílchez Espínola A; Rodríguez Prieto MA; Maldonado Campos A
    Rev Esp Anestesiol Reanim; 2002 Mar; 49(3):171. PubMed ID: 12136466
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in blood coagulation factors and fibrinolytic activity in leukemias].
    EFENDIEV FA; ABDULLAEV MM; BAKHSHIEVA EB
    Probl Gematol Pereliv Krovi; 1961 Oct; 6():19-28. PubMed ID: 13889347
    [No Abstract]   [Full Text] [Related]  

  • 14. [EXISTENCE OF CHANGES IN HEMOSTASIS WITH DECREASED FIBRINOLYSIS. BASIS FOR THE HEMOSTATIC TREATMENT WITH EPSILON AMINOCAPROIC ACID IN NON FIBRINOLYTIC HEMORRHAGIC DIATHESIS].
    CASTILLO R; SERRANO J; CARALPS A; VINAS M
    Med Clin (Barc); 1963 Oct; 41():302-6. PubMed ID: 14125259
    [No Abstract]   [Full Text] [Related]  

  • 15. FIBRINOLYTIC BLEEDING AND ITS MANAGEMENT.
    SHERRY S; FLETCHER AP; ALKJAERSIG N
    Ann N Y Acad Sci; 1964 Jul; 115():481-92. PubMed ID: 14192857
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemorrhage from fibrinolysis in pulmonary surgery; report of a case with study of coagulation mechanism.
    LAFORET EG; WALKER W
    J Thorac Surg; 1956 Oct; 32(4):548-54. PubMed ID: 13368232
    [No Abstract]   [Full Text] [Related]  

  • 17. [Disorders of coagulation/fibrinolysis and bleeding tendency].
    Endo T; Amemiya N; Kume S
    Nihon Rinsho; 1994 Jan; 52(1):119-23. PubMed ID: 8114280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CIRCULATING FIBRINOLYTIC ACTIVATOR AND HEMORRHAGIC DIATHESIS.
    ENDE N; AUDITORE JV
    Ann Surg; 1963 Jul; 158(1):117-25. PubMed ID: 14042622
    [No Abstract]   [Full Text] [Related]  

  • 19. [PHYSIOLOGICAL BLOOD COAGULATION STUDIES IN HEMORRHAGES AFTER TONSILLECTOMY AND ADENOIDECTOMY].
    MESSEK H; SAILER S
    Monatsschr Ohrenheilkd Laryngorhinol; 1963; 97():178-91. PubMed ID: 14081046
    [No Abstract]   [Full Text] [Related]  

  • 20. [INHIBITORS OF FIBRINOLYSIS IN THE TREATMENT OF HEMORRHAGE, HEMORRHAGIC DIATHESIS AND SOME OTHER PATHOLOGICAL CONDITIONS. I. SPECIFIC INHIBITORS OF FIBRINOLYSIS].
    NIEWIAROWSKI S
    Pol Arch Med Wewn; 1964; 34():211-7. PubMed ID: 14151493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.